6533b7dcfe1ef96bd1273477

RESEARCH PRODUCT

Effect of part-time cardiac catheterization facilities in patients with acute myocardial infarction

ÁNgela Díaz-pastorLeticia Jaulent-huertasLuciano Consuegra-sánchezMarta Vicente-gilabertJuan Sanchis-forésJosé Galcerá-tomásNuria Alonso-fernándezAntonio Melgarejo-morenoGermán Escudero-garcíaJuan Martínez-hernándezFrancisco J. Gil-sánchez

subject

MaleCardiac Catheterizationmedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentMyocardial InfarctionLong Term Adverse Effects030204 cardiovascular system & hematologyLower riskAngina PectorisAngina03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineHospital AdministrationInternal medicineSecondary PreventionmedicineHumansHospital Mortalitycardiovascular diseases030212 general & internal medicineMyocardial infarctionCardiac catheterizationbusiness.industryPercutaneous coronary interventionLength of Staymedicine.diseaseSurvival AnalysisOrganizational InnovationSpainCardiac Care FacilitiesEmergency medicineConventional PCICardiologyFemaleCardiology and Cardiovascular Medicinebusiness

description

Although the easy availability of invasive cardiac care facilities is associated with an increase in their use, their influence on outcomes is not clear. We sought to investigate whether a newly available cardiac catheterization laboratory (CCL) performing percutaneous coronary intervention (PCI) on a part-time (PT) basis might improve outcomes in patients with acute myocardial infarction (AMI).This was an observational cohort study that included all consecutive patients with AMI admitted to a secondary-level hospital in Spain before and after the PT-CCL opened in January 2006: during 1998-2005 and 2006-2014, respectively. All-cause in-hospital and long-term mortality were the co-primary endpoints. In-hospital complications and length of stay were secondary endpoints. For the analyses, patients were stratified according to propensity-score (PS) quintiles.A total of 5339 patients were recruited, and 50.3% were managed after the opening of the PT-CCL. The PT-CCL was associated with greater use of PCI (81.2 vs. 32.5%, p0.001) and guidelines-recommended medication (all p0.001), lower risk of recurrent angina (PS-adjusted RR=0.160, 95% CI 0.115-0.222) and shorter length of hospital stay (PS-adjusted RR for length of stay8days=0.357, 95% CI 0.301-0.422). In patients with NSTEMI, PT-CCL was associated with improved long-term survival (PS-adjusted HR=0.764, 95% CI 0.602-0.970).In patients with AMI, a new PT-CCL was associated with greater use of PCI and guideline-recommended medication, lower risk of recurrent angina and shorter length of hospital stay. In a subset of patients with NSTEMI, PT-CCL was associated with improved long-term survival.

https://doi.org/10.1016/j.ijcard.2017.02.148